CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells
Authors:
- Ujjwal RathoreURUjjwal Rathore
- Paige HaasPHPaige Haas
- Vigneshwari Easwar KumarVKVigneshwari Easwar Kumar
- Joseph HiattJHJoseph Hiatt
- Kelsey M. HaasKHKelsey M. Haas
- Mehdi BouhaddouMBMehdi Bouhaddou
- Danielle L. SwaneyDSDanielle L. Swaney
- Erica StevensonESErica Stevenson
- Lorena Zuliani-AlvarezLZLorena Zuliani-Alvarez
- Michael J. McGregorMMMichael J. McGregor
- Charles Ochieng' OlwalCOCharles Ochieng' Olwal
Open Access
- 10 April 2024
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 15 (4) , e0222223
Abstract
During HIV infection of CD4+ T cells, ubiquitin pathways are essential to viral replication and host innate immune response; however, the role of specific E3 ubiquitin ligases is not well understood. Proteomics analyses identified 116 single-subunit E3 ubiquitin ligases expressed in activated primary human CD4+ T cells. Using a CRISPR-based arrayed spreading infectivity assay, we systematically knocked out 116 E3s from activated primary CD4+ T cells and infected them with NL4-3 GFP reporter HIV-1. We found 10 E3s significantly positively or negatively affected HIV infection in activated primary CD4+ T cells, including UHRF1 (pro-viral) and TRAF2 (anti-viral). Furthermore, deletion of either TRAF2 or UHRF1 in three JLat models of latency spontaneously increased HIV transcription. To verify this effect, we developed a CRISPR-compatible resting primary human CD4+ T cell model of latency. Using this system, we found that deletion of TRAF2 or UHRF1 initiated latency reactivation and increased virus production from primary human resting CD4+ T cells, suggesting these two E3s represent promising targets for future HIV latency reversal strategies. IMPORTANCE: HIV, the virus that causes AIDS, heavily relies on the machinery of human cells to infect and replicate. Our study focuses on the host cell’s ubiquitination system which is crucial for numerous cellular processes. Many pathogens, including HIV, exploit this system to enhance their own replication and survival. E3 proteins are part of the ubiquitination pathway that are useful drug targets for host-directed therapies. We interrogated the 116 E3s found in human immune cells known as CD4+ T cells, since these are the target cells infected by HIV. Using CRISPR, a gene-editing tool, we individually removed each of these enzymes and observed the impact on HIV infection in human CD4+ T cells isolated from healthy donors. We discovered that 10 of the E3 enzymes had a significant effect on HIV infection. Two of them, TRAF2 and UHRF1, modulated HIV activity within the cells and triggered an increased release of HIV from previously dormant or “latent” cells in a new primary T cell assay. This finding could guide strategies to perturb hidden HIV reservoirs, a major hurdle to curing HIV. Our study offers insights into HIV-host interactions, identifies new factors that influence HIV infection in immune cells, and introduces a novel methodology for studying HIV infection and latency in human immune cells.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (P50 AI150476, R01 AI120694, P01 AI063302)
- amfAR, The Foundation for AIDS Research (1110189-69-RKRL)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (DP2 DA042423-01)
- California HIV/AIDS Research Program (H22BD4486)
This publication has 82 references indexed in Scilit:
- Novel role of UHRF1 in the epigenetic repression of the latent HIV-1EBioMedicine, 2022
- ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV InfectionCell Host & Microbe, 2019
- In Vitro and In Vivo Models of HIV Latency2018
- Types of Ubiquitin LigasesCell, 2016
- BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral LatencyCell Host & Microbe, 2015
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureCell, 2013
- The Cytoplasmic Domain of the HIV-1 Glycoprotein gp41 Induces NF-κB Activation through TGF-β-Activated Kinase 1Cell Host & Microbe, 2012
- HIV-1 Vif versus the APOBEC3 cytidine deaminases: An intracellular duel between pathogen and host restriction factorsMolecular Aspects of Medicine, 2010
- Genome-Scale RNAi Screen for Host Factors Required for HIV ReplicationCell Host & Microbe, 2008
- Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 ReplicationCell, 2008